AGT and renal fibrosis: In the present study, treatment with BSHX reduced pyroptosis induced by Ang II in a dose-dependent manner, suggesting that BSHX treatment has the potential to alleviate renal fibrosis, possibly by mitigating the occurrence of pyroptosis.